-
The Economic Burden of Acromegaly Disease in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Reimbursement Decisions for Advanced Oncology Combination Therapies in England and Japan
Sep 9, 2025, 16:22 PM -
Evaluating a Potential Link Between Alprazolam and Intracranial Aneurysm: A Pharmacovigilance and Bioinformatics Approach Through FAERS and Molecular Docking
Sep 9, 2025, 16:22 PM -
Navigating the Influence of Traditional Chinese Medicine (TCM) on the Positioning of New Treatments in China: A Review of TCM Inclusion in Clinical Guidelines
Sep 9, 2025, 16:22 PM -
Evaluating the Validity of Immunotherapy in Retreatment and Rechallenge Strategies for Oncology Patients
Sep 9, 2025, 16:22 PM -
Cost-Savings Analysis of Fitusiran Prophylaxis: Reducing Breakthrough Bleeding Treatment Expenditure in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review of Prognostic Factors in Advanced Merkel Cell Carcinoma
Sep 9, 2025, 16:22 PM -
Indirect Treatment Comparisons in Health Technology Assessment Submissions: A Review and Critique of Best Practice
Sep 9, 2025, 16:22 PM -
Baseline Characteristics and Treatment Persistence in UK Patients With Moderate-to-Severe UC Following 12-Week Mirikizumab Induction: Real-World Data From IBD BioResource
Sep 9, 2025, 16:22 PM -
A Review of Information Uncertainty in Oncology Treatment Preferences
Sep 9, 2025, 16:22 PM -
Generative A-Powered Extraction of Immune-Related Adverse Events From Oncology Case Reports
Sep 9, 2025, 16:22 PM -
Qualitative Trial Interviews to Explore the Experience of Adult and Pediatric Patients Participating in a Pivotal Phase 3 Trial of DTX401 for Glycogen Storage Disease Type Ia
Sep 9, 2025, 16:22 PM -
Operational and Economic Impact of CLL Treatment Regimens: Insights From a Multidisciplinary Study in Portugal
Sep 9, 2025, 16:22 PM -
Economic Burden and Health-Related Quality of Life Associated With Schizophrenia in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Global Trade Shocks and Exchange Rate Effects on Pharmaceutical Reference Pricing: Implications of EU Stimulus for US MFN Policy
Sep 9, 2025, 16:22 PM -
The Role of Body Fat in the Regulation of Male Fertility
Sep 9, 2025, 16:22 PM -
Real-World Adherence to Nonhormonal Therapies for Menopause-Related Vasomotor Symptoms: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
External Control Arm for PHAROS Trial Patients With Metastatic BRAF V600e Mutated NSCLC Treated With First-Line Encorafenib Plus Binimetinib Using Real-World Data From the French ESME Lung Cancer Database (ERASME STUDY)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Aztreonam Avibactam (ATMAVI) ± Metronidazole (MTZ) for the Treatment of Complicated Intra-Abdominal Infections (cIAIs) and Ventilator-Associated Hospital-Acquired Pneumonia (HAP/VAP) Caused by Suspected MBL-Producing...
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Access and Pricing Timelines for Innovative Medicines in the US, Europe, and Japan Pre- and Post-Pricing Reform 2021-2025
Sep 9, 2025, 16:22 PM
